As of 2025-01-24, the Relative Valuation of Pfizer Inc (PFE) is 17.59 USD. This relative valuation is based on P/E multiples. With the latest stock price at 26.44 USD, the upside of Pfizer Inc based on Relative Valuation is -33.5%.
The range of the Relative Valuation is 9.61 - 25.78 USD.
| Range | Selected | |
| Trailing P/E multiples | 30.2x - 34.4x | 31.0x |
| Forward P/E multiples | 29.5x - 47.8x | 36.6x |
| Fair Price | 9.61 - 25.78 | 17.59 |
| Upside | -63.7% - -2.5% | -33.5% |
| Date | P/E |
| 2025-01-23 | 35.24 |
| 2025-01-22 | 34.67 |
| 2025-01-21 | 35.51 |
| 2025-01-17 | 35.05 |
| 2025-01-16 | 35.31 |
| 2025-01-15 | 34.95 |
| 2025-01-14 | 35.20 |
| 2025-01-13 | 35.72 |
| 2025-01-10 | 35.61 |
| 2025-01-08 | 35.80 |
| 2025-01-07 | 36.16 |
| 2025-01-06 | 35.84 |
| 2025-01-03 | 35.44 |
| 2025-01-02 | 35.47 |
| 2024-12-31 | 35.36 |
| 2024-12-30 | 35.21 |
| 2024-12-27 | 35.48 |
| 2024-12-26 | 35.40 |
| 2024-12-24 | 35.64 |
| 2024-12-23 | 35.60 |
| 2024-12-20 | 35.13 |
| 2024-12-19 | 34.35 |
| 2024-12-18 | 34.51 |
| 2024-12-17 | 35.23 |
| 2024-12-16 | 33.65 |
| 2024-12-13 | 34.09 |
| 2024-12-12 | 33.81 |
| 2024-12-11 | 33.63 |
| 2024-12-10 | 34.08 |
| 2024-12-09 | 34.79 |
| 2024-12-06 | 34.29 |
| 2024-12-05 | 34.25 |
| 2024-12-04 | 33.63 |
| 2024-12-03 | 34.07 |
| 2024-12-02 | 34.41 |
| 2024-11-29 | 34.93 |
| 2024-11-27 | 34.43 |
| 2024-11-26 | 34.35 |
| 2024-11-25 | 34.88 |
| 2024-11-22 | 34.19 |
| 2024-11-21 | 33.49 |
| 2024-11-20 | 33.24 |
| 2024-11-19 | 33.45 |
| 2024-11-18 | 33.13 |
| 2024-11-15 | 33.05 |
| 2024-11-14 | 34.68 |
| 2024-11-13 | 35.61 |
| 2024-11-12 | 34.91 |
| 2024-11-11 | 34.97 |
| 2024-11-08 | 35.61 |